Sebban Sandrine
Dr. Sebban is in private practice in Paris, France.
J Clin Aesthet Dermatol. 2020 Jun;13(6):61-66. Epub 2020 Jun 1.
There is currently no standardized and reproducible injection technique to address facial aging at all anatomical levels. The Sebban Technique One-point (STOP) Facial Aging Method™ for hyaluronic acid (HA) fillers aims to provide predictive results using a single point of entry. STOP combines two complementary techniques: Deep One-point (DOP) and Superficial One-point (SOP). DOP targets the deep plane to restructure the facial architecture, while SOP targets the superficial and deeper hypodermic planes to add volume and provide optimal tissue hydration. The injection procedure involves one DOP phase and two SOP phases using an HA filler appropriate for the treatment indication and injection depth. STOP has been investigated in a retrospective, open-label observational case series. Data from 10 women, aged 41 to 59 years, with varying stages of facial aging were retrospectively examined. Eight had received DOP with bolus injections of a cohesive HA filler and nine had received SOP using an HA filler with good elasticity to target the deep or superficial hypodermis. The mean total volume of HA filler injected (all HA fillers combined) was 5.46mL (range: 4.0-7.0mL) for the whole face. Physician and patient satisfaction with the treatment was high and all subjects stated that they would recommend the treatment to their friends. The STOP protocol was well-tolerated and no complications were observed during the DOP or SOP phases. STOP is a reproducible and safe technique for global facial rejuvenation with a single cannular point of entry.
目前，尚无标准化且可重复的注射技术能解决所有解剖层面的面部衰老问题。用于透明质酸（HA）填充剂的塞班单点（STOP）面部抗衰方法™旨在通过单一进针点实现可预测的效果。STOP结合了两种互补技术：深部单点（DOP）和浅部单点（SOP）。DOP针对深层平面来重塑面部结构，而SOP针对浅部和较深的皮下平面以增加容积并提供最佳的组织水合作用。注射程序包括一个使用适合治疗指征和注射深度的HA填充剂的DOP阶段和两个SOP阶段。已在一项回顾性、开放标签观察性病例系列研究中对STOP进行了调查。回顾性检查了10名年龄在41至59岁之间、面部衰老程度不同的女性的数据。其中8名接受了使用粘性HA填充剂推注的DOP，9名接受了使用具有良好弹性的HA填充剂针对深部或浅部皮下组织的SOP。全脸注射的HA填充剂的平均总体积（所有HA填充剂合计）为5.46mL（范围：4.0 - 7.0mL）。医生和患者对治疗的满意度很高，所有受试者均表示会向朋友推荐该治疗。STOP方案耐受性良好，在DOP或SOP阶段均未观察到并发症。STOP是一种通过单一套管进针点实现全面部年轻化的可重复且安全的技术。
